10-QPeriod: Q1 FY2020

ECOLAB INC. Quarterly Report for Q1 Ended Mar 31, 2020

Filed May 7, 2020For Securities:ECL

Summary

Ecolab Inc. reported net sales of $3.58 billion for the first quarter ended March 31, 2020, a 2% increase year-over-year. The company's operating income also saw a healthy increase of 8% to $397.2 million. Despite a 4% decrease in net income attributable to Ecolab to $283.4 million and a slight dip in diluted EPS to $0.97, the company demonstrated resilience amidst a challenging economic environment, likely impacted by the early stages of the COVID-19 pandemic and significant events in the energy markets. The company highlighted increased sales in its Global Industrial, Global Institutional, and Global Healthcare & Life Sciences segments, though the Upstream Energy segment experienced a decline. Significant "special charges" were noted, primarily related to the planned separation of the Upstream Energy business and restructuring activities, which impacted net income. Ecolab maintained a strong liquidity position with $1.66 billion in cash and cash equivalents, and continues to execute its strategic objectives, including an agreement to acquire CID Lines, expected to close in the second quarter of 2020.

Financial Highlights

55 data points
Beta

Revenue

$3.02B

43.1% Gross Margin

Net Income

$283.40M

9.4% Net Margin

EPS (Diluted)

$0.97

Total Assets

$22.34B

Cash & Equivalents

$1.55B

Free Cash Flow

$224.10M

Financial Statements
Beta
Revenue$3.02B
Cost of Revenue$1.72B
Gross Profit$1.30B
SG&A Expenses$908.30M
Operating Income$376.20M
Interest Expense$52.50M
Net Income$283.40M
EPS (Basic)$0.98
EPS (Diluted)$0.97
Shares Outstanding (Basic)288.80M
Shares Outstanding (Diluted)292.60M

Key Highlights

  • 1Net sales increased by 2% to $3.58 billion compared to the prior year's first quarter.
  • 2Operating income rose by 8% to $397.2 million, demonstrating operational efficiency.
  • 3The company maintained a strong cash position, ending the quarter with $1.66 billion in cash and cash equivalents.
  • 4Significant "special charges" totaling $61.5 million were incurred, largely due to the planned ChampionX separation and restructuring activities, impacting net income.
  • 5Sales growth was observed in Global Industrial, Global Institutional, and Global Healthcare & Life Sciences segments, while Upstream Energy sales decreased by 3%.
  • 6Ecolab announced an agreement to acquire CID Lines, expected to close in Q2 2020, reflecting continued strategic growth initiatives.
  • 7Diluted EPS decreased slightly to $0.97, reflecting the impact of special charges and other factors.

Frequently Asked Questions

Ecolab reported net sales of $3.58 billion for the first quarter ended March 31, 2020, representing a 2% increase compared to $3.51 billion in the same period of 2019. This growth was driven by increases in both product and equipment sales, and service and lease sales.

The planned separation of the Upstream Energy business (ChampionX) resulted in significant "special charges" of $36.6 million during the first quarter of 2020. These charges are primarily related to professional fees supporting the separation process. While the separation is a strategic move, these costs impacted the quarter's profitability.

Ecolab maintained a strong liquidity position, ending the quarter with $1.66 billion in cash and cash equivalents. Total debt stood at $7.8 billion, with a net debt to EBITDA ratio of 2.0. The company also has a $2.0 billion credit facility and recently executed a $500 million revolving credit agreement in April 2020 to ensure ample liquidity.

Profitability was impacted by several factors. While reported operating income increased 8%, net income attributable to Ecolab decreased 4% to $283.4 million. This was primarily due to $61.5 million in special charges (including restructuring, ChampionX separation, and product recall costs), and a higher reported tax rate of 20.3% compared to 11.4% in the prior year, influenced by discrete tax items. Excluding these items, adjusted diluted EPS increased by 10%.